XHKG
6877
, Last price
HKD
Name
CLSA Premium Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
87.75%
Div Yld LY
—
Div Yld TTM
—
Revenues
110m
+26.98%
Net income
-7m
L
CFO
-656k
L-96.70%
Dividend
May 19, 20150.00618 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Engaged in the distribution of health-related goods and services, Top Eminent Healthcare Group Limited operates as an investment holding company, with its activities spanning Australia, Hong Kong, and New Zealand.
Key people
Rongjun Zhang
Regional Financial Controller - New Zealand and Australia · since 2002
Fei Wu
General Manager, Executive Director · since 2019
Feng Yuan
Deputy Chief Executive Officer, Executive Director · since 2019
Chi Hang So
Head of Investment of KVB AU
Stephen Gregory McCoy
Non-Executive Director · since 2011
Jian Qiang Xu
Non-Executive Director · since 2018
Christopher Wesley Satterfield
Non-Executive Independent Director · since 2019
Jianfeng Wu
Non-Executive Independent Director · since 2019
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||